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Case reports
Neuromyelitis optica (NMO, Devic's disease) is a severe
autoimmune disorder predominantly involving optic
nerves and spinal cord [1]. Usually isolated, it has been
associated with systemic autoimmune diseases in adult
patients [2]. We report 2 children with a systemic autoim-
mune disease who developed NMO. Patients were female;
NMO symptoms started at age 8 and 12 years. Patient 1
had a diagnosis of Systemic Lupus Erythematosus (SLE)
(fever, cytopenias, mesangeal glomerulonephritis, posi-
tive ANA, anti-DNA, anti-Sm). She developed vomiting,
tremor, hyperreflexia, paresthesia, neurogenic bladder
and progressive vision loss 2 years after SLE onset. Neuro-
radiological investigations disclosed longitudinally exten-
sive transverse myelitis and bilateral optic nerve
involvement. Patient 2 had recurrent parotitis for 1 year
before she developed vision loss, papilitis, dystonia and
paresthesia. She exhibited positive ANA, anti-Ro and anti-
La, and objective eye dryness. MRI evidenced lesions in
brainstem and spinal cord, and evoked potentials
revealed optic nerve involvement. A diagnosis of Sjögren's
Syndrome (SS) associated with NMO was made. NMO-Ig
was detected in both patients' sera. Intravenous and p.o.
high dose steroids, a 6-month course of monthly I.V.
cyclophosphamide (up to 1 g/m2/dose), followed by aza-
thioprine (2–3 mg/Kg/day) as maintenance therapy, were
used in both (plasmapheresis in one). Visual, motor and
sensitive symptoms dramatically improved. Mild relapses
occurred in both children; they were successfully treated
with steroids. Patients are currently well, with improved
vision and residual lesions in MRI.
Conclusion
NMO can occur in the setting SLE or SS in children. Inten-
sive immunosuppressive therapy may induce remission
and prevent visual loss.
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